(2R)-2-amino-N-[(2S)-1-[[(3S,6S,12S,15S,18R,21S,24S,27S,28R)-18-[3-[[amino-[(3-bromophenyl)carbamoylamino]methylidene]amino]propyl]-6-[(1S)-2-amino-1-hydroxy-2-oxoethyl]-15-[(2S)-butan-2-yl]-12-[(1S)-1-hydroxyethyl]-3-(hydroxymethyl)-24-[(1R)-1-hydroxy-2-methylpropyl]-21-(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-28-phenyl-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide

C65H101BrN16O18 — CID 59432187

IUPAC(2R)-2-amino-N-[(2S)-1-[[(3S,6S,12S,15S,18R,21S,24S,27S,28R)-18-[3-[[amino-[(3-bromophenyl)carbamoylamino]methylidene]amino]propyl]-6-[(1S)-2-amino-1-hydroxy-2-oxoethyl]-15-[(2S)-butan-2-yl]-12-[(1S)-1-hydroxyethyl]-3-(hydroxymethyl)-24-[(1R)-1-hydroxy-2-methylpropyl]-21-(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-28-phenyl-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide
SMILESCC[C@H](C)[C@@H]1NC(=O)[C@@H](CCC/N=C(\N)NC(=O)Nc2cccc(Br)c2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@H](O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](N)CC(C)C)[C@@H](c2ccccc2)OC(=O)[C@H](CO)NC(=O)[C@H]([C@H](O)C(N)=O)NC(=O)CNC(=O)[C@H]([C@H](C)O)NC1=O
InChIInChI=1S/C65H101BrN16O18/c1-12-34(10)45-59(94)79-46(35(11)84)58(93)71-28-44(85)77-48(51(87)53(68)88)61(96)76-43(29-83)63(98)100-52(36-18-14-13-15-19-36)49(81-57(92)42(26-32(6)7)74-54(89)39(67)24-30(2)3)62(97)80-47(50(86)33(8)9)60(95)75-41(25-31(4)5)56(91)73-40(55(90)78-45)22-17-23-70-64(69)82-65(99)72-38-21-16-20-37(66)27-38/h13-16,18-21,27,30-35,39-43,45-52,83-84,86-87H,12,17,22-26,28-29,67H2,1-11H3,(H2,68,88)(H,71,93)(H,73,91)(H,74,89)(H,75,95)(H,76,96)(H,77,85)(H,78,90)(H,79,94)(H,80,97)(H,81,92)(H4,69,70,72,82,99)/t34-,35-,39+,40+,41-,42-,43-,45-,46-,47-,48-,49-,50+,51-,52+/m0/s1
InChIKeyRSOJUPVYUUSBAW-YUTYIQEISA-N
MW1474.52 g/mol
LogP-2.81
Rot. Bonds24

About (2R)-2-amino-N-[(2S)-1-[[(3S,6S,12S,15S,18R,21S,24S,27S,28R)-18-[3-[[amino-[(3-bromophenyl)carbamoylamino]methylidene]amino]propyl]-6-[(1S)-2-amino-1-hydroxy-2-oxoethyl]-15-[(2S)-butan-2-yl]-12-[(1S)-1-hydroxyethyl]-3-(hydroxymethyl)-24-[(1R)-1-hydroxy-2-methylpropyl]-21-(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-28-phenyl-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide

(2R)-2-amino-N-[(2S)-1-[[(3S,6S,12S,15S,18R,21S,24S,27S,28R)-18-[3-[[amino-[(3-bromophenyl)carbamoylamino]methylidene]amino]propyl]-6-[(1S)-2-amino-1-hydroxy-2-oxoethyl]-15-[(2S)-butan-2-yl]-12-[(1S)-1-hydroxyethyl]-3-(hydroxymethyl)-24-[(1R)-1-hydroxy-2-methylpropyl]-21-(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-28-phenyl-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide (PubChem CID 59432187) has the molecular formula C65H101BrN16O18 and a molecular weight of 1474.52 g/mol. Its IUPAC name is (2R)-2-amino-N-[(2S)-1-[[(3S,6S,12S,15S,18R,21S,24S,27S,28R)-18-[3-[[amino-[(3-bromophenyl)carbamoylamino]methylidene]amino]propyl]-6-[(1S)-2-amino-1-hydroxy-2-oxoethyl]-15-[(2S)-butan-2-yl]-12-[(1S)-1-hydroxyethyl]-3-(hydroxymethyl)-24-[(1R)-1-hydroxy-2-methylpropyl]-21-(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-28-phenyl-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide.

Molecular Properties

Compound Name(2R)-2-amino-N-[(2S)-1-[[(3S,6S,12S,15S,18R,21S,24S,27S,28R)-18-[3-[[amino-[(3-bromophenyl)carbamoylamino]methylidene]amino]propyl]-6-[(1S)-2-amino-1-hydroxy-2-oxoethyl]-15-[(2S)-butan-2-yl]-12-[(1S)-1-hydroxyethyl]-3-(hydroxymethyl)-24-[(1R)-1-hydroxy-2-methylpropyl]-21-(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-28-phenyl-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide
PubChem CID59432187
Molecular FormulaC65H101BrN16O18
Molecular Weight1474.52 g/mol
Exact Mass1472.67
IUPAC Name(2R)-2-amino-N-[(2S)-1-[[(3S,6S,12S,15S,18R,21S,24S,27S,28R)-18-[3-[[amino-[(3-bromophenyl)carbamoylamino]methylidene]amino]propyl]-6-[(1S)-2-amino-1-hydroxy-2-oxoethyl]-15-[(2S)-butan-2-yl]-12-[(1S)-1-hydroxyethyl]-3-(hydroxymethyl)-24-[(1R)-1-hydroxy-2-methylpropyl]-21-(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-28-phenyl-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide
SMILESCC[C@H](C)[C@@H]1NC(=O)[C@@H](CCC/N=C(\N)NC(=O)Nc2cccc(Br)c2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@H](O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](N)CC(C)C)[C@@H](c2ccccc2)OC(=O)[C@H](CO)NC(=O)[C@H]([C@H](O)C(N)=O)NC(=O)CNC(=O)[C@H]([C@H](C)O)NC1=O
InChIInChI=1S/C65H101BrN16O18/c1-12-34(10)45-59(94)79-46(35(11)84)58(93)71-28-44(85)77-48(51(87)53(68)88)61(96)76-43(29-83)63(98)100-52(36-18-14-13-15-19-36)49(81-57(92)42(26-32(6)7)74-54(89)39(67)24-30(2)3)62(97)80-47(50(86)33(8)9)60(95)75-41(25-31(4)5)56(91)73-40(55(90)78-45)22-17-23-70-64(69)82-65(99)72-38-21-16-20-37(66)27-38/h13-16,18-21,27,30-35,39-43,45-52,83-84,86-87H,12,17,22-26,28-29,67H2,1-11H3,(H2,68,88)(H,71,93)(H,73,91)(H,74,89)(H,75,95)(H,76,96)(H,77,85)(H,78,90)(H,79,94)(H,80,97)(H,81,92)(H4,69,70,72,82,99)/t34-,35-,39+,40+,41-,42-,43-,45-,46-,47-,48-,49-,50+,51-,52+/m0/s1
InChIKeyRSOJUPVYUUSBAW-YUTYIQEISA-N
XLogP-2.81
TPSA546.84 Ų
H-Bond Donors19
H-Bond Acceptors20
Rotatable Bonds24
Heavy Atoms100
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001474.52
LogP ≤ 5-2.81
H-Bond Donors ≤ 519
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze (2R)-2-amino-N-[(2S)-1-[[(3S,6S,12S,15S,18R,21S,24S,27S,28R)-18-[3-[[amino-[(3-bromophenyl)carbamoylamino]methylidene]amino]propyl]-6-[(1S)-2-amino-1-hydroxy-2-oxoethyl]-15-[(2S)-butan-2-yl]-12-[(1S)-1-hydroxyethyl]-3-(hydroxymethyl)-24-[(1R)-1-hydroxy-2-methylpropyl]-21-(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-28-phenyl-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-2-amino-N-[(2S)-1-[[(3S,6S,12S,15S,18R,21S,24S,27S,28R)-18-[3-[[amino-[(3-bromophenyl)carbamoylamino]methylidene]amino]propyl]-6-[(1S)-2-amino-1-hydroxy-2-oxoethyl]-15-[(2S)-butan-2-yl]-12-[(1S)-1-hydroxyethyl]-3-(hydroxymethyl)-24-[(1R)-1-hydroxy-2-methylpropyl]-21-(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-28-phenyl-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide?
The IUPAC name of (2R)-2-amino-N-[(2S)-1-[[(3S,6S,12S,15S,18R,21S,24S,27S,28R)-18-[3-[[amino-[(3-bromophenyl)carbamoylamino]methylidene]amino]propyl]-6-[(1S)-2-amino-1-hydroxy-2-oxoethyl]-15-[(2S)-butan-2-yl]-12-[(1S)-1-hydroxyethyl]-3-(hydroxymethyl)-24-[(1R)-1-hydroxy-2-methylpropyl]-21-(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-28-phenyl-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide (CID 59432187) is (2R)-2-amino-N-[(2S)-1-[[(3S,6S,12S,15S,18R,21S,24S,27S,28R)-18-[3-[[amino-[(3-bromophenyl)carbamoylamino]methylidene]amino]propyl]-6-[(1S)-2-amino-1-hydroxy-2-oxoethyl]-15-[(2S)-butan-2-yl]-12-[(1S)-1-hydroxyethyl]-3-(hydroxymethyl)-24-[(1R)-1-hydroxy-2-methylpropyl]-21-(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-28-phenyl-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide.
What is the SMILES notation for (2R)-2-amino-N-[(2S)-1-[[(3S,6S,12S,15S,18R,21S,24S,27S,28R)-18-[3-[[amino-[(3-bromophenyl)carbamoylamino]methylidene]amino]propyl]-6-[(1S)-2-amino-1-hydroxy-2-oxoethyl]-15-[(2S)-butan-2-yl]-12-[(1S)-1-hydroxyethyl]-3-(hydroxymethyl)-24-[(1R)-1-hydroxy-2-methylpropyl]-21-(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-28-phenyl-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide?
The canonical SMILES for (2R)-2-amino-N-[(2S)-1-[[(3S,6S,12S,15S,18R,21S,24S,27S,28R)-18-[3-[[amino-[(3-bromophenyl)carbamoylamino]methylidene]amino]propyl]-6-[(1S)-2-amino-1-hydroxy-2-oxoethyl]-15-[(2S)-butan-2-yl]-12-[(1S)-1-hydroxyethyl]-3-(hydroxymethyl)-24-[(1R)-1-hydroxy-2-methylpropyl]-21-(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-28-phenyl-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide is CC[C@H](C)[C@@H]1NC(=O)[C@@H](CCC/N=C(\N)NC(=O)Nc2cccc(Br)c2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@H](O)C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](N)CC(C)C)[C@@H](c2ccccc2)OC(=O)[C@H](CO)NC(=O)[C@H]([C@H](O)C(N)=O)NC(=O)CNC(=O)[C@H]([C@H](C)O)NC1=O.
What is the InChIKey of (2R)-2-amino-N-[(2S)-1-[[(3S,6S,12S,15S,18R,21S,24S,27S,28R)-18-[3-[[amino-[(3-bromophenyl)carbamoylamino]methylidene]amino]propyl]-6-[(1S)-2-amino-1-hydroxy-2-oxoethyl]-15-[(2S)-butan-2-yl]-12-[(1S)-1-hydroxyethyl]-3-(hydroxymethyl)-24-[(1R)-1-hydroxy-2-methylpropyl]-21-(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-28-phenyl-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide?
The InChIKey is RSOJUPVYUUSBAW-YUTYIQEISA-N. The full InChI is InChI=1S/C65H101BrN16O18/c1-12-34(10)45-59(94)79-46(35(11)84)58(93)71-28-44(85)77-48(51(87)53(68)88)61(96)76-43(29-83)63(98)100-52(36-18-14-13-15-19-36)49(81-57(92)42(26-32(6)7)74-54(89)39(67)24-30(2)3)62(97)80-47(50(86)33(8)9)60(95)75-41(25-31(4)5)56(91)73-40(55(90)78-45)22-17-23-70-64(69)82-65(99)72-38-21-16-20-37(66)27-38/h13-16,18-21,27,30-35,39-43,45-52,83-84,86-87H,12,17,22-26,28-29,67H2,1-11H3,(H2,68,88)(H,71,93)(H,73,91)(H,74,89)(H,75,95)(H,76,96)(H,77,85)(H,78,90)(H,79,94)(H,80,97)(H,81,92)(H4,69,70,72,82,99)/t34-,35-,39+,40+,41-,42-,43-,45-,46-,47-,48-,49-,50+,51-,52+/m0/s1.
What are the key properties of (2R)-2-amino-N-[(2S)-1-[[(3S,6S,12S,15S,18R,21S,24S,27S,28R)-18-[3-[[amino-[(3-bromophenyl)carbamoylamino]methylidene]amino]propyl]-6-[(1S)-2-amino-1-hydroxy-2-oxoethyl]-15-[(2S)-butan-2-yl]-12-[(1S)-1-hydroxyethyl]-3-(hydroxymethyl)-24-[(1R)-1-hydroxy-2-methylpropyl]-21-(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-28-phenyl-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide?
(2R)-2-amino-N-[(2S)-1-[[(3S,6S,12S,15S,18R,21S,24S,27S,28R)-18-[3-[[amino-[(3-bromophenyl)carbamoylamino]methylidene]amino]propyl]-6-[(1S)-2-amino-1-hydroxy-2-oxoethyl]-15-[(2S)-butan-2-yl]-12-[(1S)-1-hydroxyethyl]-3-(hydroxymethyl)-24-[(1R)-1-hydroxy-2-methylpropyl]-21-(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-28-phenyl-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide has a molecular weight of 1474.52 g/mol, XLogP of -2.81, 24 rotatable bonds, 19 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-amino-N-[(2S)-1-[[(3S,6S,12S,15S,18R,21S,24S,27S,28R)-18-[3-[[amino-[(3-bromophenyl)carbamoylamino]methylidene]amino]propyl]-6-[(1S)-2-amino-1-hydroxy-2-oxoethyl]-15-[(2S)-butan-2-yl]-12-[(1S)-1-hydroxyethyl]-3-(hydroxymethyl)-24-[(1R)-1-hydroxy-2-methylpropyl]-21-(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-28-phenyl-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide is sourced from PubChem (CID 59432187), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).